ID   MK12_RAT                Reviewed;         367 AA.
AC   Q63538;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 181.
DE   RecName: Full=Mitogen-activated protein kinase 12;
DE            Short=MAP kinase 12;
DE            Short=MAPK 12;
DE            EC=2.7.11.24;
DE   AltName: Full=Extracellular signal-regulated kinase 6;
DE            Short=ERK-6;
DE   AltName: Full=Mitogen-activated protein kinase p38 gamma;
DE            Short=MAP kinase p38 gamma;
DE   AltName: Full=Stress-activated protein kinase 3;
GN   Name=Mapk12; Synonyms=Sapk3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=8925912; DOI=10.1016/0014-5793(96)00255-4;
RA   Mertens S., Craxton M., Goedert M.;
RT   "SAP kinase-3, a new member of the family of mammalian stress-activated
RT   protein kinases.";
RL   FEBS Lett. 383:273-276(1996).
RN   [2]
RP   INTERACTION WITH SNTA1, FUNCTION IN PHOSPHORYLATION OF SNTA1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=19135240; DOI=10.1016/j.cell.2008.11.018;
RA   Sumara G., Formentini I., Collins S., Sumara I., Windak R., Bodenmiller B.,
RA   Ramracheya R., Caille D., Jiang H., Platt K.A., Meda P., Aebersold R.,
RA   Rorsman P., Ricci R.;
RT   "Regulation of PKD by the MAPK p38delta in insulin secretion and glucose
RT   homeostasis.";
RL   Cell 136:235-248(2009).
RN   [3]
RP   FUNCTION, PHOSPHORYLATION AT THR-183 AND TYR-185, AND MUTAGENESIS OF
RP   THR-183 AND TYR-185.
RX   PubMed=10438538; DOI=10.1074/jbc.274.33.23570;
RA   Conrad P.W., Rust R.T., Han J., Millhorn D.E., Beitner-Johnson D.;
RT   "Selective activation of p38alpha and p38gamma by hypoxia. Role in
RT   regulation of cyclin D1 by hypoxia in PC12 cells.";
RL   J. Biol. Chem. 274:23570-23576(1999).
RN   [4]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11991731; DOI=10.1006/jmcc.2001.1523;
RA   Court N.W., dos Remedios C.G., Cordell J., Bogoyevitch M.A.;
RT   "Cardiac expression and subcellular localization of the p38 mitogen-
RT   activated protein kinase member, stress-activated protein kinase-3
RT   (SAPK3).";
RL   J. Mol. Cell. Cardiol. 34:413-426(2002).
RN   [5]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH SH3BP5.
RX   PubMed=15158451; DOI=10.1016/j.bbrc.2004.04.148;
RA   Court N.W., Kuo I., Quigley O., Bogoyevitch M.A.;
RT   "Phosphorylation of the mitochondrial protein Sab by stress-activated
RT   protein kinase 3.";
RL   Biochem. Biophys. Res. Commun. 319:130-137(2004).
RN   [6]
RP   INTERACTION WITH LIN7C; SCRIB AND SYNJ2BP, AND ACTIVITY REGULATION.
RX   PubMed=15878399; DOI=10.1016/j.bbamcr.2004.11.008;
RA   Court N.W., Ingley E., Klinken S.P., Bogoyevitch M.A.;
RT   "Outer membrane protein 25-a mitochondrial anchor and inhibitor of stress-
RT   activated protein kinase-3.";
RL   Biochim. Biophys. Acta 1744:68-75(2005).
RN   [7]
RP   REVIEW ON ACTIVITY REGULATION, AND REVIEW ON FUNCTION.
RX   PubMed=20626350; DOI=10.1042/bj20100323;
RA   Cuadrado A., Nebreda A.R.;
RT   "Mechanisms and functions of p38 MAPK signalling.";
RL   Biochem. J. 429:403-417(2010).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Serine/threonine kinase which acts as an essential component
CC       of the MAP kinase signal transduction pathway. MAPK12 is one of the
CC       four p38 MAPKs which play an important role in the cascades of cellular
CC       responses evoked by extracellular stimuli such as pro-inflammatory
CC       cytokines or physical stress leading to direct activation of
CC       transcription factors such as ELK1 and ATF2. Accordingly, p38 MAPKs
CC       phosphorylate a broad range of proteins and it has been estimated that
CC       they may have approximately 200 to 300 substrates each. Some of the
CC       targets are downstream kinases such as MAPKAPK2, which are activated
CC       through phosphorylation and further phosphorylate additional targets.
CC       Plays a role in myoblast differentiation and also in the down-
CC       regulation of cyclin D1 in response to hypoxia in adrenal cells
CC       suggesting MAPK12 may inhibit cell proliferation while promoting
CC       differentiation. Phosphorylates DLG1. Following osmotic shock, MAPK12
CC       in the cell nucleus increases its association with nuclear DLG1,
CC       thereby causing dissociation of DLG1-SFPQ complexes. This function is
CC       independent of its catalytic activity and could affect mRNA processing
CC       and/or gene transcription to aid cell adaptation to osmolarity changes
CC       in the environment. Regulates UV-induced checkpoint signaling and
CC       repair of UV-induced DNA damage and G2 arrest after gamma-radiation
CC       exposure. MAPK12 is involved in the regulation of SLC2A1 expression and
CC       basal glucose uptake in L6 myotubes; and negatively regulates SLC2A4
CC       expression and contraction-mediated glucose uptake in adult skeletal
CC       muscle. C-Jun (JUN) phosphorylation is stimulated by MAPK14 and
CC       inhibited by MAPK12, leading to a distinct AP-1 regulation. MAPK12 is
CC       required for the normal kinetochore localization of PLK1, prevents
CC       chromosomal instability and supports mitotic cell viability. MAPK12-
CC       signaling is also positively regulating the expansion of transient
CC       amplifying myogenic precursor cells during muscle growth and
CC       regeneration. {ECO:0000269|PubMed:10438538,
CC       ECO:0000269|PubMed:19135240}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.24;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.24;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Binds 2 magnesium ions.;
CC   -!- ACTIVITY REGULATION: Activated by phosphorylation on threonine and
CC       tyrosine. MAP2K3/MKK3 and MAP2K6/MKK6 are both essential for the
CC       activation of MAPK12 induced by environmental stress, whereas
CC       MAP2K6/MKK6 is the major MAPK12 activator in response to TNF-alpha.
CC       {ECO:0000269|PubMed:15878399}.
CC   -!- SUBUNIT: Monomer. Interacts with the PDZ domain of the syntrophin
CC       SNTA1. Interacts with LIN7C, SCRIB, SYNJ2BP and SH3BP5. Interacts with
CC       PTPN4; this interaction induces the activation of PTPN4 phosphatase
CC       activity. {ECO:0000250|UniProtKB:P53778, ECO:0000269|PubMed:15158451,
CC       ECO:0000269|PubMed:15878399, ECO:0000269|PubMed:19135240}.
CC   -!- INTERACTION:
CC       Q63538; Q13424: SNTA1; Xeno; NbExp=5; IntAct=EBI-783937, EBI-717191;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus {ECO:0000250}. Mitochondrion.
CC       Note=Mitochondrial when associated with SH3BP5. In skeletal muscle
CC       colocalizes with SNTA1 at the neuromuscular junction and throughout the
CC       sarcolemma.
CC   -!- TISSUE SPECIFICITY: Highly expressed in skeletal muscle, lung and
CC       testes and also in the heart and thymus of both adult and neonatal
CC       rats. {ECO:0000269|PubMed:11991731}.
CC   -!- DOMAIN: The TXY motif contains the threonine and tyrosine residues
CC       whose phosphorylation activates the MAP kinases.
CC   -!- PTM: Dually phosphorylated on Thr-183 and Tyr-185 by MAP2K3/MKK3 and
CC       MAP2K6/MKK6, which activates the enzyme. {ECO:0000269|PubMed:10438538}.
CC   -!- PTM: Ubiquitinated. Ubiquitination leads to degradation by the
CC       proteasome pathway (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. MAP kinase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X96488; CAA65342.1; -; mRNA.
DR   PIR; S68680; S68680.
DR   RefSeq; NP_068514.1; NM_021746.1.
DR   AlphaFoldDB; Q63538; -.
DR   SMR; Q63538; -.
DR   BioGRID; 248795; 2.
DR   DIP; DIP-37835N; -.
DR   IntAct; Q63538; 3.
DR   STRING; 10116.ENSRNOP00000046455; -.
DR   iPTMnet; Q63538; -.
DR   PhosphoSitePlus; Q63538; -.
DR   jPOST; Q63538; -.
DR   PaxDb; 10116-ENSRNOP00000046455; -.
DR   Ensembl; ENSRNOT00000044376.5; ENSRNOP00000046455.3; ENSRNOG00000031233.6.
DR   Ensembl; ENSRNOT00055020204; ENSRNOP00055016288; ENSRNOG00055011877.
DR   Ensembl; ENSRNOT00060043149; ENSRNOP00060035708; ENSRNOG00060024912.
DR   Ensembl; ENSRNOT00065028049; ENSRNOP00065022165; ENSRNOG00065016800.
DR   GeneID; 60352; -.
DR   KEGG; rno:60352; -.
DR   AGR; RGD:70975; -.
DR   CTD; 6300; -.
DR   RGD; 70975; Mapk12.
DR   eggNOG; KOG0660; Eukaryota.
DR   GeneTree; ENSGT00940000156189; -.
DR   HOGENOM; CLU_000288_181_1_1; -.
DR   InParanoid; Q63538; -.
DR   OMA; PYVAAYH; -.
DR   OrthoDB; 158564at2759; -.
DR   PhylomeDB; Q63538; -.
DR   TreeFam; TF105100; -.
DR   Reactome; R-RNO-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-RNO-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-RNO-525793; Myogenesis.
DR   Reactome; R-RNO-5675221; Negative regulation of MAPK pathway.
DR   PRO; PR:Q63538; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000031233; Expressed in skeletal muscle tissue and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; ISO:RGD.
DR   GO; GO:0004707; F:MAP kinase activity; IDA:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0045445; P:myoblast differentiation; ISO:RGD.
DR   GO; GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB.
DR   CDD; cd07880; STKc_p38gamma; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR050117; MAP_kinase.
DR   InterPro; IPR003527; MAP_kinase_CS.
DR   InterPro; IPR038786; MAPK12.
DR   InterPro; IPR008352; MAPK_p38-like.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   PANTHER; PTHR24055; MITOGEN-ACTIVATED PROTEIN KINASE; 1.
DR   PANTHER; PTHR24055:SF146; MITOGEN-ACTIVATED PROTEIN KINASE 12; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR01773; P38MAPKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS01351; MAPK; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell cycle; Cytoplasm; Kinase; Magnesium; Metal-binding;
KW   Mitochondrion; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Stress response;
KW   Transcription; Transcription regulation; Transferase; Ubl conjugation.
FT   CHAIN           1..367
FT                   /note="Mitogen-activated protein kinase 12"
FT                   /id="PRO_0000186284"
FT   DOMAIN          27..311
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOTIF           183..185
FT                   /note="TXY"
FT   ACT_SITE        153
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         33..41
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         56
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         183
FT                   /note="Phosphothreonine; by MAP2K3 and MAP2K6"
FT                   /evidence="ECO:0000269|PubMed:10438538"
FT   MOD_RES         185
FT                   /note="Phosphotyrosine; by MAP2K3 and MAP2K6"
FT                   /evidence="ECO:0000269|PubMed:10438538"
FT   MUTAGEN         183
FT                   /note="T->A: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:10438538"
FT   MUTAGEN         185
FT                   /note="Y->A: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:10438538"
SQ   SEQUENCE   367 AA;  41985 MW;  B77193D9F45E1D4E CRC64;
     MSSPPPARKG FYRQEVTKTA WEVRAVYQDL QPVGSGAYGA VCSAVDSRTG NKVAIKKLYR
     PFQSELFAKR AYRELRLLKH MRHENVIGLL DVFTPDETLD DFTDFYLVMP FMGTDLGKLM
     KHETLSEDRI QFLVYQMLKG LKYIHAAGVI HRDLKPGNLA VNEDCELKIL DFGLARQADS
     EMTGYVVTRW YRAPEVILNW MRYTQTVDIW SVGCIMAEMI TGKILFKGND HLDQLKEIMK
     VTGTPPPEFV QKLQSAEAKN YMEGLPELEK KDFASVLTNA SPQAVNLLEK MLVLDAEQRV
     TAAEALAHPY FESLRDTEDE PKAQKYDDSF DDVDRTLEEW KRVTYKEVLS FKPPRQLGAR
     VPKETAL
//
